May 4, 2026 · Form 4 insider transaction
MARAGANORE JOHN bought 17,974 shares of Hemab Therapeutics Holdings, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
The warrant was granted on January 29, 2026. The shares underlying the warrant vest over three years in equal monthly installments from January 1, 2026 through January 1, 2029.